← Evidence map

ArticleBlood2023

Steffin DHM, Muhsen IN, Hill LC, et al. Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022;140(1):16-24.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Steffin DHM, Muhsen IN, Hill LC, et al. Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022;140(1):16-24. | OpenQuestion